NCT03429192已完成不适用
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,653
- 试验地点
- 9
- 主要终点
- Difference in overall survival (OS)
研究概览
简要总结
A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases
详细描述
A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with surgeries from 2014 to 2017;
- •Pathologically diagnosed patients with non-small cell lung cancer;
- •Age > 18 years old;
- •Patients with chest surgeries before hospitalization;
- •Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group 10 and 11 lymph nodes);
排除标准
- •Patients with radiotherapies, chemotherapies and biological therapies for tumors
结局指标
主要结局
Difference in overall survival (OS)
时间窗: 2014 - 2017
OS difference in the subgroups of N2 patients with lymph skip metastases and non-skip metastases
次要结局
- Percentage of N2 patients with lymph skip metastases(2014 - 2017)
研究者
Lingyu Huang
Professor
Tianjin Chest Hospital
研究点 (9)
Loading locations...
相似试验
已完成
不适用
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung CancerNon-small Cell Lung CancerNCT03427567Tongji Hospital3,902
Unknown
不适用
A Study to Explore Prognoses of NSCLC Patients Complicated With OligometastasesNon Small Cell Lung CancerNCT03427541Tang-Du Hospital1,000
已完成
2 期
Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung CancerNon-Small Cell Lung CancerNCT00051974Millennium Pharmaceuticals, Inc.155
已完成
不适用
Chemotherapy in Treating Patients With Lung CancerNon Small Cell Lung CancerNCT01067794Eli Lilly and Company1,610
进行中（未招募）
1 期
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung CancerNCT03401385Daiichi Sankyo Co., Ltd.890